ID29970A - Metode untuk mengobati penyakit neovaskuler okuler - Google Patents

Metode untuk mengobati penyakit neovaskuler okuler

Info

Publication number: ID29970A
Authority: ID; Indonesia
Prior art keywords: treating; oulner; methods; neovascular disease; neovascular
Prior art date: 1998-11-23

Application number

IDW00200101090A

Other languages

English (en)

Indonesian (id)

Inventor

Romulus Kimbro Brazzell

Jeanette Marjorie Wood

Peter Anthony Campochiaro

Frances Elizabeth Kane

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-23

Filing date

1999-11-22

Publication date

2001-10-25

1999-11-22 Application filed by Novartis Ag filed Critical Novartis Ag

2001-10-25 Publication of ID29970A publication Critical patent/ID29970A/id

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
208000005590 Choroidal Neovascularization Diseases 0.000 abstract 1
206010060823 Choroidal neovascularisation Diseases 0.000 abstract 1
206010029113 Neovascularisation Diseases 0.000 abstract 1
208000007135 Retinal Neovascularization Diseases 0.000 abstract 1
230000002207 retinal effect Effects 0.000 abstract 1
HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical class C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IDW00200101090A 1998-11-23 1999-11-22 Metode untuk mengobati penyakit neovaskuler okuler ID29970A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US19867798A	1998-11-23	1998-11-23

Publications (1)

Publication Number	Publication Date
ID29970A true ID29970A (id)	2001-10-25

Family

ID=22734344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101090A ID29970A (id)	1998-11-23	1999-11-22	Metode untuk mengobati penyakit neovaskuler okuler

Country Status (18)

Country	Link
EP (1)	EP1131073B1 (de)
JP (2)	JP2002530342A (de)
KR (1)	KR100698449B1 (de)
CN (1)	CN1172673C (de)
AT (1)	ATE252387T1 (de)
AU (1)	AU761092B2 (de)
BR (1)	BR9915569A (de)
CA (1)	CA2348890C (de)
DE (1)	DE69912304T2 (de)
DK (1)	DK1131073T3 (de)
ES (1)	ES2211197T3 (de)
ID (1)	ID29970A (de)
IL (2)	IL142757A0 (de)
NO (1)	NO328085B1 (de)
NZ (1)	NZ511559A (de)
PT (1)	PT1131073E (de)
WO (1)	WO2000030651A1 (de)
ZA (1)	ZA200103925B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0122318D0 (en) *	2001-09-14	2001-11-07	Novartis Ag	Organic compounds
US20030119812A1 (en) *	2001-11-08	2003-06-26	Brazzell Romulus Kimbro	Method for decreasing capillary permeability in the retina
WO2004009056A1 (en) *	2002-07-23	2004-01-29	Novartis Ag	Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
MX2007001155A (es) *	2004-07-29	2007-08-14	Creabilis Therapeutics Spa	Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
CN101580515B (zh) *	2008-05-16	2011-06-08	上海医药工业研究院	一种星形孢菌素提取纯化的方法
WO2010104933A1 (en)	2009-03-11	2010-09-16	Merck Sharp & Dohme Corp.	Inhibitors of akt activity
WO2010114780A1 (en)	2009-04-01	2010-10-07	Merck Sharp & Dohme Corp.	Inhibitors of akt activity
CN102924479A (zh) *	2011-08-09	2013-02-13	山东鲁北药业有限公司	一种星孢菌素类衍生物的半合成方法
EP2755482B1 (de)	2011-09-15	2016-06-01	Merck Sharp & Dohme Corp.	Kombination von mk-1775 und mk-8776 zur behandlung von krebs
DK2925888T3 (en)	2012-11-28	2017-12-18	Merck Sharp & Dohme	COMPOSITIONS AND METHODS OF CANCER TREATMENT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5093330A (en) *	1987-06-15	1992-03-03	Ciba-Geigy Corporation	Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) *	1987-06-15	1988-11-30	Ciba Geigy Ag	Derivatives substituted at methyl-amino nitrogen
EP0651650A4 (de) *	1992-07-08	1996-04-17	Celtrix Pharma	METHODE ZUR BEHANDLUNG VON AUGENKRANKHEITEN MITTELS TGF--g(b).
US6410322B1 (en) *	1993-07-27	2002-06-25	Hybridon Inc	Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
WO1997034920A1 (en) *	1996-03-21	1997-09-25	Sugen, Inc.	Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) *	1996-05-01	2003-03-17	Елі Ліллі Енд Компані	Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
EP1061913B1 (de) *	1998-03-13	2007-06-27	The Johns Hopkins University School Of Medicine	Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie

1999
- 1999-11-22 CN CNB99813600XA patent/CN1172673C/zh not_active Expired - Fee Related
- 1999-11-22 ID IDW00200101090A patent/ID29970A/id unknown
- 1999-11-22 AT AT99957321T patent/ATE252387T1/de active
- 1999-11-22 EP EP99957321A patent/EP1131073B1/de not_active Expired - Lifetime
- 1999-11-22 IL IL14275799A patent/IL142757A0/xx active IP Right Grant
- 1999-11-22 ES ES99957321T patent/ES2211197T3/es not_active Expired - Lifetime
- 1999-11-22 BR BR9915569-9A patent/BR9915569A/pt not_active Application Discontinuation
- 1999-11-22 NZ NZ511559A patent/NZ511559A/xx not_active IP Right Cessation
- 1999-11-22 WO PCT/EP1999/008987 patent/WO2000030651A1/en not_active Ceased
- 1999-11-22 JP JP2000583534A patent/JP2002530342A/ja not_active Ceased
- 1999-11-22 AU AU15066/00A patent/AU761092B2/en not_active Ceased
- 1999-11-22 DE DE69912304T patent/DE69912304T2/de not_active Expired - Lifetime
- 1999-11-22 KR KR1020017006415A patent/KR100698449B1/ko not_active Expired - Fee Related
- 1999-11-22 DK DK99957321T patent/DK1131073T3/da active
- 1999-11-22 PT PT99957321T patent/PT1131073E/pt unknown
- 1999-11-22 CA CA002348890A patent/CA2348890C/en not_active Expired - Fee Related
2001
- 2001-04-23 IL IL142757A patent/IL142757A/en not_active IP Right Cessation
- 2001-05-15 ZA ZA200103925A patent/ZA200103925B/en unknown
- 2001-05-21 NO NO20012490A patent/NO328085B1/no not_active IP Right Cessation
2011
- 2011-02-07 JP JP2011023933A patent/JP2011088938A/ja active Pending

Also Published As

Publication number	Publication date
CA2348890C (en)	2009-05-12
JP2002530342A (ja)	2002-09-17
ES2211197T3 (es)	2004-07-01
DE69912304T2 (de)	2004-07-22
AU761092B2 (en)	2003-05-29
KR100698449B1 (ko)	2007-03-23
AU1506600A (en)	2000-06-13
CN1172673C (zh)	2004-10-27
ATE252387T1 (de)	2003-11-15
PT1131073E (pt)	2004-03-31
DK1131073T3 (da)	2004-02-02
EP1131073A1 (de)	2001-09-12
CA2348890A1 (en)	2000-06-02
CN1328462A (zh)	2001-12-26
NO20012490D0 (no)	2001-05-21
BR9915569A (pt)	2001-08-14
NZ511559A (en)	2004-01-30
WO2000030651A1 (en)	2000-06-02
DE69912304D1 (de)	2003-11-27
EP1131073B1 (de)	2003-10-22
JP2011088938A (ja)	2011-05-06
HK1040182A1 (en)	2002-05-31
IL142757A (en)	2007-07-04
ZA200103925B (en)	2002-07-25
NO328085B1 (no)	2009-11-30
KR20010078398A (ko)	2001-08-20
IL142757A0 (en)	2002-03-10
NO20012490L (no)	2001-06-25

Publication	Publication Date	Title
DE60138137D1 (de)	2009-05-07	Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
LU91928I2 (fr)	2012-03-09	Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DK0841949T3 (da)	2006-08-21	Anvendelse af saccharid-konjugater
EP1173484A4 (de)	2003-05-21	Behandlung von fibrose durch antagonismus zwischen il-13 und il-13-rezeptorketten
DE69834658D1 (de)	2006-06-29	Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
PT971713E (pt)	2003-09-30	Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ECSP045098A (es)	2004-07-23	Procedimientos para tratar enfermedades neovasculares oculares
ATE323482T1 (de)	2006-05-15	Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten
AP2002002596A0 (en)	2002-09-30	Piperazine and piperidine derivatives.
BR9811012A (pt)	2000-10-17	"uso de um composto".
DE69305776D1 (de)	1996-12-12	Behandlung neurodegenerativer Krankheiten
AP2004003124A0 (en)	2004-09-30	Thiazole and oxazole derivatives which modulate PPAR activity
BR0210241A (pt)	2004-08-10	Piranoindazóis e seu uso no tratamento de glaucoma
DE69940951D1 (de)	2009-07-16	Nd wachstumshemmende mittel
NO990912D0 (no)	1999-02-25	Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
MY119375A (en)	2005-05-31	Treatment of tinnitus using neuroprotective agents
PL359027A1 (pl)	2004-08-23	Udoskonalone leczenie neowaskularyzacji
DE69613386D1 (de)	2001-07-19	Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
BR9915569A (pt)	2001-08-14	Método para o tratamento de doenças neovasculares oculares
EP1110554A4 (de)	2002-02-06	Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE60130872D1 (de)	2007-11-22	Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
WO2000009098A3 (en)	2000-05-18	Method for treating ocular neovascular diseases
EE200100026A (et)	2002-06-17	Oksasolidinoonid silmahaiguste raviks
SE9403160D0 (sv)	1994-09-21	Method and means for prevention and treatment of secondary cataract
DE69916013D1 (de)	2004-05-06	Vorderkammerimplantat zur behandlung des phaken auges